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Abstract 
 
Some new substituted 1,3,5 triazine with 1,2,4 triazole and substituted urea/thiourea were synthesized and 
evaluated for their in vitro antimicrobial activity against Gram positive and Gram negative strains using a 
microdilution procedure. Synthesized compounds 1a to 1i prove to be effective with MIC (mg ml
-1
), among 
them 1c, 1e, 1g showed excellent activity against a panel of microorganisms. The newly synthesized 
compounds were characterized using IR, 
1
H-NMR and elemental analysis.  
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Introduction:- 
s-Triazine derivatives represent an important class of compounds due to their potential to be biologically active. 
They are known to be anti-protozoals[1], anticancer agents[2], estrogen receptor modulators[3], antimalarials[4], 
cyclin-dependent kinase modulators[5], and antimicrobials[6]. Cyanuric chloride, an inexpensive, easily available 
reagent, of low toxicity and less corrosive than other similar reactants, has been widely used in organic 
reactions[7]. In the present research, we wish to describe a simple and efficient protocol for the rapid preparation 
of 1-(4-(3-(4-METHOXYPHENYL)THIOUREIDO)-6-(1H-1,2,4-TRIAZOL-1-YL)-1,3,5-TRIAZINE-2-YL)-
3-PHENYLUREA at different temperature  conditions. To the best of our knowledge, there are no reports on 
three-component coupling of triazole, substituted urea and thiourea to produce a title compound. An important 
class of compounds having anticancer, antitumor, antiviral and antifungal activity consists of substituted s-
triazine  
derivatives. These compounds have been used in the treatment of depression and hence gained considerable 
significance. These are valuable bases for estrogen receptor modulators [8] and also used as bridging agents to 
synthesize herbicides and in the production of drugs or polymers[9]. 
 1,3,5-Triazine derivatives[10]have displayed a broad range of biological activities including cytotoxic 
activities[11-13], antiangiogenic activity by targeting either VEGF-R2 (KDR)[14]or direct modulation of Tie-2 
tyrosine kinase phosphorylation[15], antiparasitic activities[16,17], and glucocerebrosidase inhibition with potential 
as chemical chaperones for Gaucher disease[18]. Cyanuric chloride derivatives have been studied for decades, 
especially its amino derivatives. It is generally accepted that the first chlorine of cyanuric chloride can be easily 
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substituted by NH2-group at 0–5 ◦C, the second one at 30–50 ◦C, and the third one typically above 80 ◦C, which 
depends on the activity of amine nucleophiles[19]. 
1,2,4 – Triazole have wide range of biological activities such as anti bacterial[20] , anti caner[21] , anti 
tubercular[22], anti HIV[23]  and anti depressant activity, anti tumer [24] and anti viral[24] activity, anti 
hypertensive[25] activity , analgesic and anti inflammatory[26] activity. 
Thiourea derivatives possess antibacterial [27], hypnotic antitubercular and possible anticonvulsant 
activities.  It also represent a new class of human immuno deficiency virus type (HIV-1), non-nucleoside 
reverse transcriptase (NNRT) inhibitors [28], found as antagonist [29], and high density lipoprotein (HDL) 
elevating agents [30]. Over the last few years, the thiourea moiety has been of interest to design molecules as 
receptor antagonists, as natural product mimics or as synthetic intermediates to amidines or guanidines.[31]  
Thiourea not only confers antibacterial, antitubercular or antileprotic activity, but has also been reported to 
possess antifungal as well as antiviral properties.[32] 
Urea derivatives are reported to possess antibacterial[33], antimicrobial antifungal, anticancer[34] and 
anticonvulsant[35] activities. Urea derivatives possess wide therapeutic activities such as antithyroidal[36], 
hypnotic and anesthetic[37], antibacterial[38], diuretic[39] and anthelmintics.  
We planned to undertake the synthesis and characterization of some triazine derivatives carrying the above 
biodynamic heterocyclic systems with the hope to achieve enhanced biological activity. 
 
 
Experimental:- 
General 
All the melting points were taken in open capillaries tube and are uncorrected. The purity of compounds was 
checked routinely by TLC (0.5 mm thickness)Using silica gel – G coated Al – plates (Merck) and spots were 
visualized by exposing the dry plates in iodine vapours. IR spectra were recorded on FTIR spectrophotometer 
using KBr or Nujol technique.1H NMR spectra on a Varian 400 FT MHz NMR instrument at using CDCl3 or 
DMSO-d6 as solvent and TMS as internal reference. 
Scheme:- 
STEP-1 
 PREPARATION OF 1-(4,6-DICHLORO-1,3,5-TRIAZIN-2-YL)-3-(4-
METHOXYPHENYL)THIOUREA: (A) 
To a stirred solution of cyanuric chloride (0.1 mole, 18.4 g.) in acetone (100 ml) at 0-50C, the solution of 1–(4-
methoxyphenyl)thiourea (0.1 mole,17.3g) in acetone (45 ml)  was added and pH being maintained neutral by 
the addition of 10% sodium bi-carbonate solution from time to time as per requirement of reaction condition. 
The stirring was continued at   0-5°C for 2 hours. After the completion of reaction the stirring was stopped and 
the solution was treated with crushed ice. The solid product obtained was filtered and dried. The crude product 
was purified by crystallization from absolute alcohol to get title compound. 
 
 
STEP-2 
PREPARATION   OF 1-(4-CHLORO-6-(1 H-1,2,4-TRIAZOL-1-YL)-1,3,5-TRIAZINE-2-YL)-3-(4-
METHOXYPHENYL) THIOUREA : (B) 
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To a stirred solution of (A) (0.1 mole, 33.0 g) in acetone (100 ml) was added, the solution of 1,2,4 triazole (0.1 
mole, 6.9 g ) in acetone (25 ml) was added drop wise maintaining the temperature at 40°C, the pH being 
maintained neutral by the addition of 10% sodium bi-carbonate solution from time to time as per requirement of 
reaction condition. The temperature was gradually raised to 45°C during three hours. After the completion of 
reaction, the resultant content was poured into ice-cold water. The solid product obtained was filtered and dried. 
The crude product was purified by crystallization from absolute alcohol to get the title compound. 
 
 
STEP-3 
PREPARATION OF FINAL COMPOUND:-      
A mixture of (B) (0.01 mole, 3.62 g) and aryl urea (0.01 mole) in DMF (20ml) was refluxed in oil bath. The 
temperature was gradually raised to 80-1000C during four hours, the pH being maintained neutral by the 
addition of 10% sodium bi-carbonate solution from time to time as per requirement of reaction condition. After 
the completion of reaction, add little charcoal in R.B.F. and then filter it into cold water. The solid product 
obtained was filtered and dried. The crude product was purified by recrystallization from absolute alcohol. 
Prepare all derivatives by this method. Analytical data are given below. 
 
 
ROUTE OF SYNTHESIS :- 
STEP-1 
 
            [A]          
                                                                                                     
         STEP-2 
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    [B]  
 
 
     STEP-3 
    
 
 
WHERE R = given in below table. 
 
Table 1 Physical data of synthesized compounds:- 
Sr. No. R Mol. Formula Mol. Weight M.P. 
OC        Yield                 % 
1a H C20H18N10O2S 462.49 120O 60 
1b 2-OCH3 C21H20N10O3S 492.51 122 O 61 
1c 4-CH3 C21H20N10O2S 476.51 190 O 59 
1d 4-Cl C20H17ClN10O2S 496.93 220 O 74 
1e 4-OCH3 C21H20N10O3S 492.51 140 O 59 
1f 2-CH3 C21H20N10O2S 476.51 140 O 58 
1g 2-Cl C20H17ClN10O2S 496.93 135 O 62 
1h 4-Br C20H17BrN10O2S 541.38 180 O 60 
1i 4-F C20H17FN10O2S 480.48 175 O 65 
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Compound (1a):  Yield: 60%; m.p. 1200C (dec.); IR (KBr,cm-1) : 798 cm-1    
(-C=N- s-triazine) 818.47  cm-1(1,4 Di sub. in  benzene)  1416.15 cm-1(>N-,30 amine) 1548.50 cm-1(-NH-
def)1656.15 cm-1 (-C=O-) 3290.15 cm-1(-NH-str)  2800.50 cm-1(–OCH3 str) 1170.64 cm-1(-C=S-)1023.14 cm-1 (-
N-N-str) 1H-NMR:δ 8.90(s,2H,-CONH), 10.30(s,2H,-CSNH),3.64(s,3H, -OCH3), 7.20-7.98 (m,11H, Ar-H). 
 
Compound (1b):  Yield: 61%; m.p. 1220C (dec.); IR (KBr,cm-1) : 801 cm-1   (-C=N- s-triazine) 819.25  cm-
1(1,4 Di sub. in  benzene) 1410.98 cm-1(>N-,30 amine)1562.70cm-1 (-NH-def)1643.16 cm-1 (-C=O-) 3311.16 cm-
1(-NH-str)2916.48 cm-1 (–OCH3 str)1177.34cm-1(-C=S-)1033.34 cm-1 (-N-N-str) 1H-NMR:δ 8.64(s,2H,-CONH) 
10.22(s,2H,-CSNH),3.69(s,6H, -OCH3)7.40-7.78 (m,10H, Ar-H). 
 
Compound (1c):  Yield: 59%; m.p. 1900C (dec.); IR (KBr,cm-1) : 783.07 cm-1    
(-C=N- s-triazine) 821.07  cm-1(1,4 Di sub. in  benzene)1410.98 cm-1(>N-,30 amine) 1596.6 cm-1(-NH-def) 
1643.16cm-1 (-C=O-) 3311.16 cm-1(-NH-str) 2916.48 cm-1 (–OCH3 str) 1177.34 cm-1(-C=S-)1308.20 cm-1 (-C-
CH3 str) 1033.34 cm-1 (-N-N-str) 1H-NMR:δ 8.55(s,2H,-CONH) 10.10(s,2H,-CSNH),3.71(s,3H, -
OCH3)3.74(s,3H,C-CH3 ) 7.32-7.66 (m,10H, Ar-H). 
 
Compound (1d):  Yield: 74%; m.p. 2200C (dec.); IR (KBr,cm-1) : 795 cm-1    
(-C=N- s-triazine) 816.34  cm-1(1,4 Di sub. in  benzene) 1418.09 cm-1(>N-,30 amine)1559.90 cm-1(-NH-
def)1638.80 cm-1 (-C=O-) 3330.30 cm-1(-NH-str)2890.50 cm-1 (–OCH3 str)1180.80cm-1(-C=S-)707 cm-1(-C-Cl-
str)1029.34 cm-1 (-N-N-str) 1H-NMR:δ 8.64(s,2H,-CONH) 10.22(s,2H,-CSNH),3.69(s,3H, -OCH3)7.40-7.78 
(m,10H, Ar-H). 
 
Compound (1e):  Yield: 59%; m.p. 1400C (dec.); IR (KBr,cm-1) : 804 cm-1    
(-C=N- s-triazine) 812.40  cm-1(1,4 Di sub. in  benzene) 1416.30 cm-1(>N-,30 amine)1569.70 cm-1(-NH-
def)1651.60 cm-1 (-C=O-) 3334.11 cm-1(-NH-str)2930.30 cm-1 (–OCH3 str)1169.64cm-1(-C=S-)1028.71 cm-1 (-
N-N-str) 1H-NMR:δ 8.90(s,2H,-CONH) 10.90(s,2H,-CSNH),3.80(s,6H, -OCH3)7.50-8.18 (m,10H, Ar-H). 
 
Compound (1f):  Yield: 58%; m.p. 1400C (dec.); IR (KBr,cm-1) : 795.65 cm-1    
(-C=N- s-triazine) 819.40  cm-1(1,4 Di sub. in  benzene)1418.30 cm-1(>N-,30 amine) 1584.20 cm-1(-NH-def) 
1637.60cm-1 (-C=O-) 3320.65 cm-1(-NH-str) 2898.28 cm-1 (–OCH3 str) 1169.70 cm-1(-C=S-)1316.60 cm-1 (-C-
CH3 str) 1040.85 cm-1 (-N-N-str) 1H-NMR:δ 8.60(s,2H,-CONH) 9.95(s,2H,-CSNH),3.66(s,3H, -
OCH3)3.60(s,3H,C-CH3 ) 7.22-7.90 (m,10H, Ar-H). 
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Compound (1g):  Yield: 62%; m.p. 1350C (dec.); IR (KBr,cm-1) : 789.30 cm-1    
(-C=N- s-triazine) 825.30  cm-1(1,4 Di sub. in  benzene) 1430.10 cm-1(>N-,30 amine)1565.60 cm-1(-NH-
def)1650.70 cm-1 (-C=O-) 3310.80 cm-1(-NH-str)2900.50 cm-1 (–OCH3 str)1170.60cm-1(-C=S-)717 cm-1(-C-Cl-
str)1036.74 cm-1 (-N-N-str) 1H-NMR:δ 8.70(s,2H,-CONH) 10.29(s,2H,-CSNH),3.75(s,3H, -OCH3)7.50-7.84 
(m,10H, Ar-H). 
 
Compound (1h):  Yield: 60%; m.p. 1800C (dec.); IR (KBr,cm-1) : 797.40 cm-1 (-C=N- s-triazine) 829.90  cm-
1(1,4 Di sub. in  benzene) 1420.10 cm-1(>N-,30 amine)1560.50cm-1 (-NH-def)1654.90 cm-1 (-C=O-) 33170.55 
cm-1(-NH-str)2920.45 cm-1 (–OCH3 str) 1162.70cm-1(-C=S-)692 cm-1(-C-Br-str) 1028.47 cm-1 (-N-N-str) 1H-
NMR:δ 8.67(s,2H,-CONH) 10.75(s,2H,-CSNH),3.66(s,3H,-OCH3)7.42-7.74(m,10H, Ar-H). 
  
Compound (1i):  Yield: 65%; m.p. 1750C (dec.); IR (KBr,cm-1) : 790.30 cm-1    
(-C=N- s-triazine) 820.40  cm-1(1,4 Di sub. in  benzene) 1435.10 cm-1(>N-,30 amine)1561.50 cm-1(-NH-
def)1642.60 cm-1 (-C=O-) 3300.75 cm-1(-NH-str)2914.50 cm-1  
(–OCH3 str)1160.60cm-1(-C=S-)1055 cm-1(-C-F-str) 1040.10 cm-1 (-N-N-str) 1H-NMR:δ 8.75(s,2H,-CONH) 
10.40(s,2H,-CSNH),3.85(s,3H, -OCH3)7.70-7.94 (m,10H, Ar-H). 
 
Antimicrobial Activity 
For the testing antimicrobial activity various microorganism were used for the study. The broth dilution 
method was used for this study. Following general procedure is adopted[40].The antimicrobial activity of all the 
compounds was studies at 1000 ppm concentration in vitro. The different types of microorganism used were 
some gram negative bacteria [Escherichia coli, Pseudomonas aeruginosa], gram positive bacteria [Bacillus 
subtilis, Staphylococcus aureus] and fungus [Candida albicans]. 
 80% DMSO are used as solvent to dissolve compound 1a to 1i to 10(µg/ml). 
Conclusions:- 
A series of cyanuric chloride derivatives were prepared and tested for their in vitro antibacterial activity against 
the four strains of bacteria (gram +ve, gram –ve).Three compounds of the obtained series showed high in vitro 
antimicrobial activity. Compound (1c,1e,1g) showed excellent activity against Staphylococcus aureus. Whereas 
compound 1c has excellent activity against B. subtilis, P. aeruginosa, C. albicans. 
 
 
Sr.No 
& 
Minimum Inhibitory  Concentration (µg/ml) 
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Note: The higher value in given range is MIC but practically we can find out exact value from the given range 
by using different dilutions.(by secondary screening). 
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R 
Gram positive bacteria Gram negative bacteria Fungus 
S. aureus B. subtilis E. coli P. aeruginosa C. albicans 
1. 1a H 125-250 250-500 125-250 125-250 125-250 
2. 1b 2-OCH3 125-250 125-250 125-250 250-500 125-250 
3. 1c 4-CH3 125-250 31.25-62.5 125-250 31.25-62.5 31.25-62.5 
4. 1d 4-Cl 125-250 250-500 125-250 125-250 125-250 
5. 1e 4-OCH3 62.5-125 125-250 125-250 125-250 125-250 
6. 1f 2-CH3 125-250 125-250 125-250 125-250 125-250 
7. 1g 2-Cl 62.5-125 125-250 125-250 125-250 250-500 
8. 1h 4-Br 125-250 125-250 125-250 125-250 250-500 
9. 1i 4-F 125-250 125-250 125-250 125-250 125-250 
Ampicillin ------ 250 100 100 100 ------ 
Nystatin ------ --- --- --- --- 100 
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